Details for Patent: 10,208,307
✉ Email this page to a colleague
Which drugs does patent 10,208,307 protect, and when does it expire?
Patent 10,208,307 protects AMVUTTRA and is included in one NDA.
This patent has fifty-one patent family members in thirty-three countries.
Summary for Patent: 10,208,307
| Title: | Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases |
| Abstract: | The present invention provides iRNA agents, e.g., double stranded iRNA agents, that target the transthyretin (TTR) gene and methods of using such iRNA agents for treating or preventing TTR-associated diseases. |
| Inventor(s): | Zimmermann; Tracy (Winchester, MA), Chan; Amy (Tewksbury, MA), Jadhav; Vasant (Sharon, MA), Maier; Martin (Belmont, MA), Rajeev; Kallanthottathil G. (Wayland, MA) |
| Assignee: | Alnylam Pharmaceuticals, Inc. (Cambridge, MA) |
| Application Number: | 15/221,651 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 10,208,307
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alnylam Pharms Inc | AMVUTTRA | vutrisiran sodium | SOLUTION;SUBCUTANEOUS | 215515-001 | Jun 13, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | AMVUTTRA IS INDICATED FOR THE TREATMENT OF THE POLYNEUROPATHY OF HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS IN ADULTS | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,208,307
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3329002 | ⤷ Sign Up | 301216 | Netherlands | ⤷ Sign Up |
| European Patent Office | 3329002 | ⤷ Sign Up | PA2023505 | Lithuania | ⤷ Sign Up |
| European Patent Office | 3329002 | ⤷ Sign Up | 7/2023 | Austria | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
